Listed

Celldex Therapeutics, Inc.

CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31

Reports and events: 261 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Celldex Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2012-08-1008:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-12-004461
2012-08-0916:01 ET10-QQuarterly reportPeriod 2012-06-300001104659-12-056527
2012-06-1410:38 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-12-043506
2012-05-2418:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-12-039533
2012-05-0410:19 ET10-QQuarterly reportPeriod 2012-03-310001104659-12-032960
2012-05-0309:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-12-002467
2012-04-2409:10 ETDEF 14AProxy statementPeriod 2012-06-130001047469-12-004633
2012-04-0316:30 ET8-K1.02 Termination of a material agreement0001104659-12-023622
2012-03-0812:46 ET10-KAnnual reportPeriod 2011-12-310001047469-12-002276
2012-03-0708:00 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-12-016044
2012-02-2416:11 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-12-012515
2012-02-2316:00 ET8-K8.01 Other events0001104659-12-012137
2011-11-0312:48 ET10-QQuarterly reportPeriod 2011-09-300001104659-11-060466
2011-11-0208:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-11-006271
2011-08-0414:20 ET10-QQuarterly reportPeriod 2011-06-300001104659-11-043630
2011-08-0307:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-11-004615
2011-07-0608:37 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-11-037897
2011-06-1615:39 ET8-K5.07 Shareholder vote results0001104659-11-035114
2011-05-1816:54 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-11-029985
2011-05-0512:45 ET10-QQuarterly reportPeriod 2011-03-310001104659-11-026190
2011-05-0408:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-11-002686
2011-04-2610:26 ETDEF 14AProxy statementPeriod 2011-06-150001047469-11-004060
2011-03-0915:45 ET10-KAnnual reportPeriod 2010-12-310001047469-11-001901
2011-03-0308:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-11-001357
2011-01-0608:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-11-000565
2010-12-2316:02 ET10-Q/AQuarterly report, amendedPeriod 2010-09-300001104659-10-064202
2010-12-2316:01 ET10-K/AAnnual report, amendedPeriod 2009-12-310001104659-10-064201
2010-11-0411:38 ET10-QQuarterly reportPeriod 2010-09-300001104659-10-055897
2010-11-0209:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-10-006410
2010-09-1612:50 ET8-K5.07 Shareholder vote results0001104659-10-048815
2010-09-0716:28 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001104659-10-047511
2010-08-0513:07 ET10-QQuarterly reportPeriod 2010-06-300001104659-10-042274
2010-08-0412:16 ETDEF 14AProxy statementPeriod 2010-09-150001047469-10-006977
2010-08-0408:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-10-004681
2010-05-0614:54 ET10-QQuarterly reportPeriod 2010-03-310001104659-10-026329
2010-05-0408:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-10-002696
2010-03-3115:43 ET10-K/AAnnual report, amendedPeriod 2009-12-310001104659-10-017686
2010-03-3015:23 ET8-K9.01 Financial statements and exhibits0001104659-10-017296
2010-03-1216:19 ET10-KAnnual reportPeriod 2009-12-310001047469-10-002142
2010-03-0408:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-10-001399
2010-02-1610:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-10-007163
2010-01-2514:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-10-002734
2010-01-0812:56 ET8-K9.01 Financial statements and exhibits0001047469-10-000066
2009-12-3116:44 ET8-K2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-09-072181
2009-11-0613:46 ET10-QQuarterly reportPeriod 2009-09-300001104659-09-063266
2009-11-0613:15 ETDEF 14AProxy statementPeriod 2009-12-160001047469-09-009714
2009-11-0407:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-09-007639
2009-10-2116:56 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001047469-09-009091
2009-10-0217:49 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-09-057375
2009-09-0416:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001157523-09-006356

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.